Literature DB >> 17690501

Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.

Tomo Osako1, Takuji Iwase, Kaoru Takahashi, Kotaro Iijima, Yumi Miyagi, Seiichiro Nishimura, Keiichiro Tada, Masujiro Makita, Futoshi Akiyama, Goi Sakamoto, Fujio Kasumi.   

Abstract

PURPOSE: To investigate the relationship between the tumor size of breast cancer by palpation and the sensitivity of mammography (MMG) and ultrasonography (US), and which modality can detect nonpalpable breast cancer in women aged 30 to 39 years.
METHODS: We retrospectively evaluated the tumor size by palpation, breast density, and the sensitivity of MMG and US in 165 patients aged 30 to 39 years. Palpation, US, and MMG were performed with prior knowledge of the results of other modalities. The tumor size on palpation were classified into Tnp; nonpalpable, T1p; 2 cm or less, T2p; more than 2 cm, but not more than 5 cm, and T3p; more than 5 cm.
RESULTS: Of 165 patients, 147 patients (89%) showed mammographically dense breasts. Of 165 cancers, 14 (8%) were Tnp, 40 (24%) were T1p, 82 (50%) were T2p, and 29 (18%) were T3p. The sensitivity of MMG was 57% (8 of 14) for Tnp, 78% (31 of 40) for T1p, 90% (74 of 82) for T2p, and 97% (28 of 29) for T3p. The sensitivity of US was 43% (6 of 14) for Tnp and 100% for palpable cancers. Of 14 nonpalpable cancers, 4 (29%), 4 (29%), and 2 (14%) could be detected by only MMG, bloody nipple discharge, and US.
CONCLUSIONS: The sensitivity of MMG depends on the tumor size on palpation in this age range. MMG fails to detect relatively large palpable cancers. On the other hand, US can detect all palpable cancers. However, the sensitivity of US declines for nonpalpable cancers. For the detection of nonpalpable cancers, MMG, US, and nipple discharge are complementary modalities.

Entities:  

Mesh:

Year:  2007        PMID: 17690501     DOI: 10.2325/jbcs.14.255

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  7 in total

1.  The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience.

Authors:  C E Redmond; G M Healy; C F Murphy; A O'Doherty; A Foster
Journal:  Ir J Med Sci       Date:  2016-06-07       Impact factor: 1.568

2.  Usefulness of Organ Electrodermal Diagnostics in Detection of Breast Pathology: A Multicenter, Randomized, Double-Blinded Clinical Study.

Authors:  Jan Z Szopinski; Sarah Rayne
Journal:  Med Acupunct       Date:  2017-12-01

3.  Ultrasonography alone for diagnosis of breast cancer in women under 40.

Authors:  D C Appleton; L Hackney; S Narayanan
Journal:  Ann R Coll Surg Engl       Date:  2014-04       Impact factor: 1.891

4.  Assessment of breast cancer tumour size using six different methods.

Authors:  Martina Meier-Meitinger; Lothar Häberle; Peter A Fasching; Mayada R Bani; Katharina Heusinger; David Wachter; Matthias W Beckmann; Michael Uder; Rüdiger Schulz-Wendtland; Boris Adamietz
Journal:  Eur Radiol       Date:  2010-12-30       Impact factor: 5.315

5.  Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.

Authors:  Lore Timmermans; Luc Bleyen; Klaus Bacher; Koen Van Herck; Kim Lemmens; Chantal Van Ongeval; Andre Van Steen; Patrick Martens; Isabel De Brabander; Mathieu Goossens; Hubert Thierens
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

6.  The effect of accompanying in situ ductal carcinoma on accuracy of measuring malignant breast tumor size using B-mode ultrasonography and real-time sonoelastography.

Authors:  A A Soliman; S Wojcinski; F Degenhardt
Journal:  Int J Breast Cancer       Date:  2012-09-05

7.  Detecting Vasodilation as Potential Diagnostic Biomarker in Breast Cancer Using Deep Learning-Driven Thermomics.

Authors:  Bardia Yousefi; Hamed Akbari; Xavier P V Maldague
Journal:  Biosensors (Basel)       Date:  2020-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.